130 related articles for article (PubMed ID: 30539826)
1. PTEN and SHIP: Impact on lymphatic metastasis in breast cancer.
Li K; Li GD; Sun LY; Li XQ
J Cancer Res Ther; 2018 Dec; 14(Supplement):S937-S941. PubMed ID: 30539826
[TBL] [Abstract][Full Text] [Related]
2. PTP1B promotes aggressiveness of breast cancer cells by regulating PTEN but not EMT.
Liu X; Chen Q; Hu XG; Zhang XC; Fu TW; Liu Q; Liang Y; Zhao XL; Zhang X; Ping YF; Bian XW
Tumour Biol; 2016 Oct; 37(10):13479-13487. PubMed ID: 27465552
[TBL] [Abstract][Full Text] [Related]
3. Low mutation and neoantigen burden and fewer effector tumor infiltrating lymphocytes correlate with breast cancer metastasization to lymph nodes.
Wang Z; Liu W; Chen C; Yang X; Luo Y; Zhang B
Sci Rep; 2019 Jan; 9(1):253. PubMed ID: 30670769
[TBL] [Abstract][Full Text] [Related]
4. PTEN/PI3K/AKT protein expression is related to clinicopathological features and prognosis in breast cancer with axillary lymph node metastases.
Wang LL; Hao S; Zhang S; Guo LJ; Hu CY; Zhang G; Gao B; Zhao JJ; Jiang Y; Tian WG; Wang J; Luo DL
Hum Pathol; 2017 Mar; 61():49-57. PubMed ID: 27864123
[TBL] [Abstract][Full Text] [Related]
5. PTEN and NEDD4 in Human Breast Carcinoma.
Chen Y; van de Vijver MJ; Hibshoosh H; Parsons R; Saal LH
Pathol Oncol Res; 2016 Jan; 22(1):41-7. PubMed ID: 26276352
[TBL] [Abstract][Full Text] [Related]
6. The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancer.
Eijsink JJ; Noordhuis MG; ten Hoor KA; Kok M; Hollema H; de Bock GH; Nijman HW; Schuuring E; Wisman GB; van der Zee AG
Hum Pathol; 2010 Dec; 41(12):1735-41. PubMed ID: 21078436
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer.
Inanc M; Ozkan M; Karaca H; Berk V; Bozkurt O; Duran AO; Ozaslan E; Akgun H; Tekelioglu F; Elmali F
Med Oncol; 2014 Jan; 31(1):801. PubMed ID: 24326984
[TBL] [Abstract][Full Text] [Related]
8. [Screening of differential expression genes between primary breast cancer and its lymph node metastasis using single primer amplification of cDNA for microarray].
Hao XS; Feng YM; Zhang L; Li XQ; Niu Y; Xiao CH; Sun BC
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):385-90. PubMed ID: 15854527
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast.
Tsutsui S; Inoue H; Yasuda K; Suzuki K; Higashi H; Era S; Mori M
Oncology; 2005; 68(4-6):398-404. PubMed ID: 16020969
[TBL] [Abstract][Full Text] [Related]
10. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma.
Capodanno A; Camerini A; Orlandini C; Baldini E; Resta ML; Bevilacqua G; Collecchi P
Hum Pathol; 2009 Oct; 40(10):1408-17. PubMed ID: 19428048
[TBL] [Abstract][Full Text] [Related]
12. Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs.
Smeets A; Daemen A; Vanden Bempt I; Gevaert O; Claes B; Wildiers H; Drijkoningen R; Van Hummelen P; Lambrechts D; De Moor B; Neven P; Sotiriou C; Vandorpe T; Paridaens R; Christiaens MR
Breast Cancer Res Treat; 2011 Oct; 129(3):767-76. PubMed ID: 21116709
[TBL] [Abstract][Full Text] [Related]
13. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma.
Saal LH; Holm K; Maurer M; Memeo L; Su T; Wang X; Yu JS; Malmström PO; Mansukhani M; Enoksson J; Hibshoosh H; Borg A; Parsons R
Cancer Res; 2005 Apr; 65(7):2554-9. PubMed ID: 15805248
[TBL] [Abstract][Full Text] [Related]
14. Phosphoinositide phosphatases: just as important as the kinases.
Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA
Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between D2-40-labeled lymphatic vessel invasion and lymph node metastasis of breast cancer].
Ding GP; Ye CS; Liu MF; Zhen LF; Liao JJ
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2301-3. PubMed ID: 20965831
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling of supraglottic carcinoma: PTEN and thrombospondin 2 are associated with inhibition of lymphatic metastasis.
Bai W; Wang L; Ji W; Gao H
Acta Otolaryngol; 2009 May; 129(5):569-74. PubMed ID: 18720079
[TBL] [Abstract][Full Text] [Related]
17. Significance of lymphatic invasion combined with size of primary tumor for predicting sentinel lymph node metastasis in patients with breast cancer.
Fujii T; Yajima R; Tatsuki H; Suto T; Morita H; Tsutsumi S; Kuwano H
Anticancer Res; 2015 Jun; 35(6):3581-4. PubMed ID: 26026130
[TBL] [Abstract][Full Text] [Related]
18. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.
Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X
Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476
[TBL] [Abstract][Full Text] [Related]
19. MiR-155 expression level changes might be associated with initial phases of breast cancer pathogenesis and lymph-node metastasis.
Petrović N; Kolaković A; Stanković A; Lukić S; Řami A; Ivković M; Mandušić V
Cancer Biomark; 2016; 16(3):385-94. PubMed ID: 26889816
[TBL] [Abstract][Full Text] [Related]
20. Studying Lymphatic Metastasis in Breast Cancer: Current Models, Strategies, and Clinical Perspectives.
To B; Isaac D; Andrechek ER
J Mammary Gland Biol Neoplasia; 2020 Sep; 25(3):191-203. PubMed ID: 33034778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
